Northcape Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Northcape Wealth Management's AMGN Position: Q2 2026 in Review
Northcape Wealth Management increased its Amgen (AMGN) stake by 14% in Q2 2026, buying an estimated $127K and bringing the position to 2,974 shares worth $1.08M. The position accounts for 0.28% of the portfolio, ranked #73.
Northcape Wealth Management first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.85M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Northcape Wealth Management held 2,974 shares of Amgen worth $1.08M as of Q2 2026.
- Northcape Wealth Management bought 371 Amgen shares in Q2 2026, an estimated $127K.
- Amgen made up 0.28% of Northcape Wealth Management's portfolio in Q2 2026, its #73 holding.
- Northcape Wealth Management first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- Northcape Wealth Management's Amgen position peaked at $2.85M in Q3 2024.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Northcape Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.